Advertisement

Topics

Tibotec Pharmaceuticals Company Profile

20:47 EDT 29th March 2017 | BioPortfolio

Tibotec Pharmaceuticals, based in Cork, Ireland, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with offices in Yardley, PA. Tibotec is dedicated to the discovery and development of innovative HIV/AIDS drugs and anti-infectives for diseases of high unmet medical need.


News Articles [977 Associated News Articles listed on BioPortfolio]

M&As this week: Dendreon Pharmaceuticals, Agile Pharma, Takeda Pharmaceutical Company

Valeant Pharmaceuticals International subsidiary Dendreon Pharmaceuticals will be acquired by Sanpower Group.

Deals this week: Sucampo Pharmaceuticals, Satsuma Pharmaceuticals, Nanjing Hicin Pharmaceutical

Sucampo Pharmaceuticals has made plans for a private placement of convertible senior notes, due 2021.

Easton Pharmaceuticals and Partner BMV Medica Announce Closing Of First Distribution Agreement For Three Exclusively Licensed Women's Health Products: VagiSense, AmnioSense and Gynofit With Windsor Pharmaceuticals For Central America and The Caribbean /

TORONTO, ON -- (Marketwired) -- 10/31/16 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces it has closed its first Sales & Distribution agreement with Windsor Pharmaceuticals SA for three ...

Deals this week: Rigel Pharmaceuticals, VANC Pharmaceuticals, Provectus Biopharmaceuticals

US-based clinical-stage bio-technology company Rigel Pharmaceuticals has announced the pricing for its underwritten public offering of 20 million shares to be $2 a share.

Ritter Pharmaceuticals Announces Collaboration with University of British Columbia to Explore ...

LOS ANGELES, CA--(Marketwired - Feb 13, 2017) - Ritter Pharmaceuticals, Inc. ( NASDAQ : RTTR) ("Ritter Pharmaceuticals" or the "Company"), a developer of Read more...

BRIEF-Acetylon Pharmaceuticals entered into an agreement to be acquired by Celgene Corporation

* Acetylon Pharmaceuticals -Regenacy Pharmaceuticals to be launched by Acetylon Pharmaceuticals and Celgene Corporation agrees to complete acquisition of acetylon

Ritter Pharmaceuticals Phase 2a Lactose Intolerance Clinical Trial Microbiome Data, Published ...

LOS ANGELES, CA--(Marketwired - Jan 3, 2017) - Ritter Pharmaceuticals, Inc. ( NASDAQ : RTTR) ("Ritter Pharmaceuticals" or the "Company"), a developer of Read more...

Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides ...

LOS ANGELES, CA--(Marketwired - Feb 27, 2017) - Ritter Pharmaceuticals, Inc. ( NASDAQ : RTTR) ("Ritter Pharmaceuticals" or the "Company"), a leading developer Read more...

Drugs and Medications [0 Results]

None

PubMed Articles [156 Associated PubMed Articles listed on BioPortfolio]

Progress Confirmed for Pharmaceuticals in 2016.

n/a.

Temporal and spatial behavior of pharmaceuticals in Narragansett Bay, Rhode Island, United States.

The behavior and fate of pharmaceutical ingredients in coastal marine ecosystems is not well understood. To address this, the spatial and temporal distribution of 15 high volume pharmaceuticals were m...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.

Antibiotics and antidepressants are among the most successful drugs used for human therapy. Their concentration in influent on WWTP is relative high and there can be removed by biodegradation or sorpt...

Status of pharmaceuticals in African water bodies: Occurrence, removal and analytical methods.

In this review paper, the milestones and challenges that have been achieved and experienced by African Environmental Scientists regarding the assessment of water pollution caused by the presence of ph...

Clinical Trials [28 Associated Clinical Trials listed on BioPortfolio]

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

The primary objective of this study is to continue to provide Darunavir (DRV) to pediatric patients who previously received DRV in any of three pediatric clinical studies sponsored by Tibo...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

The primary objective of this study is to continue to provide Darunavir (DRV) to pediatric patients who previously received DRV in any of three pediatric clinical studies sponsored by Tibo...

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceut...

TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options

This is an open-label safety study to provide early access to TMC114 for HIV-1 infected patients who have failed and exhausted regimens based on commercially available antiretroviral (ARV)...

Companies [1254 Associated Companies listed on BioPortfolio]

Tibotec Pharmaceuticals Ltd.

Tibotec Pharmaceuticals Ltd., based in Cork, Ireland, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with off...

Tibotec Pharmaceuticals

Tibotec Pharmaceuticals, based in Cork, Ireland, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with offices in Y...

Tibotec Inc.

Tibotec Inc., based in Yardley, Pa., USA, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with offices in Cork, Ir...

Tibotec, Inc

Tibotec is a pharmaceutical research and development company dedicated to the discovery and development of innovative new drugs for HIV/AIDS and other infectious diseases of high unmet medical need. T...

Tibotec-HIV.com

Nil

More Information about "Tibotec Pharmaceuticals" on BioPortfolio

We have published hundreds of Tibotec Pharmaceuticals news stories on BioPortfolio along with dozens of Tibotec Pharmaceuticals Clinical Trials and PubMed Articles about Tibotec Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tibotec Pharmaceuticals Companies in our database. You can also find out about relevant Tibotec Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record